Effects of Exenatide on Measures of Diabetic Neuropathy in Subjects With Type 2 Diabetes: Results From an 18-Month Proof-Of-Concept Open-Label Randomized Study

Journal of Diabetes and its Complications- Netherlands

doi 10.1016/j.jdiacomp.2015.07.013

Full Text

Abstract

Available in

Date

Authors

Publisher

Elsevier BV

Related search

Effects of Exenatide Plus Rosiglitazone on -Cell Function and Insulin Sensitivity in Subjects With Type 2 Diabetes on Metformin

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2010English

Effects of Fenofibrate in Patients With Type 2 Diabetes Mellitus Complicated by Diabetic Neuropathy

Diabetes Mellitus
Internal MedicineEndocrinologyMetabolismDiabetes
2010English

Exenatide Add-On to Continuous Subcutaneous Insulin Infusion Therapy Reduces Bolus Insulin Doses in Patients With Type 2 Diabetes: A Randomized, Controlled, Open-Label Trial

Diabetes Therapy
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Autologous Bone Marrow Mononuclear Cell Therapy for Autism: An Open Label Proof of Concept Study

Stem Cells International
Cell BiologyMolecular Biology
2013English

Efficacy of Benfluorex in Combination With Sulfonylurea in Type 2 Diabetic Patients: An 18-Week, Randomized, Double-Blind Study

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2006English

Lower Corneal Nerve Fibre Length Identifies Diabetic Neuropathy in Older Adults With Diabetes: Results From the Canadian Study of Longevity in Type 1 Diabetes

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2017English

Fitness Consultations in Routine Care of Patients With Type 2 Diabetes in General Practice: An 18-Month Non-Randomised Intervention Study

BMC Family Practice
Family Practice
2010English

Effects of Light Fingertip Touch on Postural Responses in Subjects With Diabetic Neuropathy

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2003English

Lithium Efficacy in Bipolar Depression With Flexible Dosing: A Six-Week, Open-Label, Proof-Of-Concept Study

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy